Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Covidien to purchase superDimension

Covidien has entered into a definitive agreement to purchase a developer of minimally invasive interventional pulmonology devices, superDimension.

Under the agreement, Covidien will purchase all of the capital stock of superDimension for approximately $300m, with future earn out payments possible.

The transaction including receipt of certain regulatory approvals is scheduled to be completed in the second quarter of 2012.

Covidien said assuming a second quarter 2012 closing, it expects this transaction not to have a material impact on its fiscal 2012 sales.

superDimension president and CEO Daniel Sullivan said this partnership will strengthen the company’s commercial infrastructure, expanding the benefits of the i-Logic system and electromagnetic navigation bronchoscopy to a wider patient population.

superDimension’s i-Logic system uses electromagnetic navigation bronchoscopy to provide minimally invasive access to lesions deep in the lungs as well as mediastinal lymph nodes.

The i-Logic system also facilitates more effective evaluation of lung lesions, potentially enabling safer, more effective tissue biopsies.